Clinical Trial

Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients

Study acronym: CPM-ICU
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial aims to evaluate whether continuous passive motion (CPM) can prevent ankle joint contracture and muscle atrophy in critically ill patients receiving mechanical ventilation in the ICU. The study will also assess the feasibility and safety of implementing CPM therapy in this population. The primary objectives are: To determine whether CPM preserves ankle dorsiflexion range of motion during ICU immobilization. To assess whether ultrasound can detect changes in tibialis anterior muscle morphology in response to CPM. In this within-subject design, each participant will receive CPM therapy on one ankle while the contralateral ankle serves as the control. Outcomes related to joint mobility and muscle condition will be compared between the two sides. Participants will: Receive CPM treatment on one ankle for 30 minutes, twice daily, for up to 7 days or until ICU discharge. Undergo goniometric and ultrasound assessments at baseline and after the intervention. Continue to receive standard ICU care throughout the study period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-13.
Trial Details
NCT Number NCT07032051
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions Ankle Contracture, Critically Ill Intensive Care Unit Patients, Muscle Atrophy
Enrollment 20 participants
Start Date 2025-06-25
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-29